Target to spend $300 million more in next year improving wages and healthcare

Go back to Target to spend $300 million more in next year improving wages and healthcare

Target (TGT) PT Raised to $290 at JPMorgan, 'More Upside Expected in Near Term'

March 1, 2022 5:33 PM EST

JPMorgan analyst Christopher Horvers raised the price target on Target (NYSE: TGT) to $290.00 (from $262.00) while maintaining a Overweight rating.

The analyst comments "TGT is a core long-term holding given its ability to compete in the new world of omni-channel retailing and its... More